This multi-disciplinary approach to immunotherapy serves as a useful survey of the latest treatments and methodologies. Utilising the immune system to beat cancer is becoming a best-practice method of treatment, but rapid upskilling is required to ensure excellent outcomes.

CTLA4 blocking antibodies are a novel immune checkpoint blockade therapy.

Please sign in to read more

Newsletter Sign Up

Be the first to receive email updates on all things CPD, keep abreast of latest industry revelations, and keep adding to your CPD point score.

Newsletter Sign up - Other Pages